Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
N/A
-275,284 Closed
0 $0
Q1 2022

May 16, 2022

BUY
N/A
275,284 New
275,284 $1.13 Million
Q1 2021

May 17, 2021

SELL
N/A
-95,522 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
N/A
-138,205 Reduced 59.13%
95,522 $381,000
Q3 2020

Nov 16, 2020

SELL
N/A
-260,094 Reduced 52.67%
233,727 $631,000
Q2 2020

Aug 13, 2020

SELL
N/A
-331,240 Reduced 40.15%
493,821 $1.36 Million
Q1 2020

May 15, 2020

BUY
N/A
136,440 Added 19.81%
825,061 $1.95 Million
Q4 2019

Feb 14, 2020

BUY
N/A
334,189 Added 94.29%
688,621 $3.24 Million
Q3 2019

Nov 14, 2019

SELL
N/A
-734,225 Reduced 67.44%
354,432 $1.18 Million
Q2 2019

Aug 14, 2019

SELL
N/A
-220 Reduced 0.02%
1,088,657 $3.58 Million
Q1 2019

May 14, 2019

BUY
N/A
220 Added 0.02%
1,088,877 $3.3 Million
Q4 2018

Feb 14, 2019

BUY
N/A
1,037,693 Added 2036.13%
1,088,657 $2.96 Million
Q3 2018

Nov 14, 2018

BUY
N/A
50,964 New
50,964 $171,000

About Antares Pharma, Inc.


  • Ticker ATRS
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 170,042,000
  • Market Cap $951M
More about ATRS
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.